These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 29074436

  • 1. DHPAC, a novel synthetic microtubule destabilizing agent, possess high anti-tumor activity in vincristine-resistant oral epidermoid carcinoma in vitro and in vivo.
    Zhang Y, Gong FL, Lu ZN, Wang HY, Cheng YN, Liu ZP, Yu LG, Zhang HH, Guo XL.
    Int J Biochem Cell Biol; 2017 Dec; 93():1-11. PubMed ID: 29074436
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
    Wang HY, Zhang Y, Zhou Y, Lu YY, Wang WF, Xin M, Guo XL.
    Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
    [Abstract] [Full Text] [Related]

  • 3. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J, Pang Y, Sheng J, Wang Y, Chen J, Hu J, Huang L, Li X.
    Biochem Pharmacol; 2015 Sep 01; 97(1):51-61. PubMed ID: 26212540
    [Abstract] [Full Text] [Related]

  • 4. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.
    Yue B, Zhao CR, Xu HM, Li YY, Cheng YN, Ke HN, Yuan Y, Wang RQ, Shi YQ, Lou HX, Qu XJ.
    Biochim Biophys Acta; 2013 Jan 01; 1830(1):2194-203. PubMed ID: 23085067
    [Abstract] [Full Text] [Related]

  • 5. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
    Lu ZN, Shi ZY, Dang YF, Cheng YN, Guan YH, Hao ZJ, Tian B, He HW, Guo XL.
    Biomed Pharmacother; 2019 Dec 01; 120():109478. PubMed ID: 31568987
    [Abstract] [Full Text] [Related]

  • 6. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY.
    Cancer Res; 2004 Jul 01; 64(13):4621-8. PubMed ID: 15231674
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN, Wang JJ, Ji YT, Zhao GD, Tang LQ, Zhang CM, Guo XL, Liu ZP.
    J Med Chem; 2016 Jun 09; 59(11):5341-55. PubMed ID: 27172319
    [Abstract] [Full Text] [Related]

  • 8. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
    Yuan Z, Wang H, Hu Z, Huang Y, Yao F, Sun S, Wu B.
    Nutr Cancer; 2015 Jun 09; 67(1):126-36. PubMed ID: 25514492
    [Abstract] [Full Text] [Related]

  • 9. A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway.
    Chiang NJ, Lin CI, Liou JP, Kuo CC, Chang CY, Chen LT, Chang JY.
    PLoS One; 2013 Jun 09; 8(3):e58953. PubMed ID: 23554962
    [Abstract] [Full Text] [Related]

  • 10. Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties.
    Wu JD, Cui YJ, Zhou YG, Tang LQ, Zhang CM, Liu ZP.
    Invest New Drugs; 2020 Feb 09; 38(1):29-38. PubMed ID: 30887253
    [Abstract] [Full Text] [Related]

  • 11. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY.
    J Pharmacol Exp Ther; 2007 Oct 09; 323(1):398-405. PubMed ID: 17660383
    [Abstract] [Full Text] [Related]

  • 12. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
    Qiao F, Zuo D, Shen X, Qi H, Wang H, Zhang W, Wu Y.
    Cancer Chemother Pharmacol; 2012 Aug 09; 70(2):259-70. PubMed ID: 22752214
    [Abstract] [Full Text] [Related]

  • 13. Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells.
    Utaipan T, Athipornchai A, Suksamrarn A, Chunsrivirot S, Chunglok W.
    Oncol Rep; 2017 Feb 09; 37(2):1243-1252. PubMed ID: 28075474
    [Abstract] [Full Text] [Related]

  • 14. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH.
    Mol Pharmacol; 2004 Jan 09; 65(1):77-84. PubMed ID: 14722239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Kim JY, Park Y, Lee BM, Kim HS, Yoon S.
    Anticancer Res; 2018 Oct 09; 38(10):5685-5692. PubMed ID: 30275188
    [Abstract] [Full Text] [Related]

  • 17. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
    Satitmanwiwat S, Changsangfa C, Khanuengthong A, Promthep K, Roytrakul S, Arpornsuwan T, Saikhun K, Sritanaudomchai H.
    Biomed Pharmacother; 2016 Dec 09; 84():1042-1050. PubMed ID: 27780132
    [Abstract] [Full Text] [Related]

  • 18. Identification of novel 1-indolyl acetate-5-nitroimidazole derivatives of combretastatin A-4 as potential tubulin polymerization inhibitors.
    Yao YF, Wang ZC, Wu SY, Li QF, Yu C, Liang XY, Lv PC, Duan YT, Zhu HL.
    Biochem Pharmacol; 2017 Aug 01; 137():10-28. PubMed ID: 28456516
    [Abstract] [Full Text] [Related]

  • 19. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
    Wang YJ, Li Q, Xiao HB, Li YJ, Yang Q, Kan XX, Chen Y, Liu XN, Weng XG, Chen X, Cai WY, Guo Y, Huang HF, Zhu XX.
    Drug Des Devel Ther; 2015 Aug 01; 9():5301-13. PubMed ID: 26445529
    [Abstract] [Full Text] [Related]

  • 20. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
    Liu MD, Xiong SJ, Tan F, Liu Y.
    Acta Pharmacol Sin; 2016 May 01; 37(5):687-97. PubMed ID: 27063218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.